37Supplies of doses of chemotherapy drugs by approved hospital authorities

37 Supplies of doses of chemotherapy drugs by approved hospital authorities

(1) Subject to section 40 of this instrument, this section sets out amounts that an approved hospital authority may charge an eligible patient for a special arrangement supply of a dose of a chemotherapy drug.

Note: Section 40 of this instrument applies to an original special arrangement supply of a dose of a chemotherapy drug if the supply is made to a CTG registered patient by a CTG supplier.

Patient co‑payment may be charged for original supply only (2) For an original supply of a dose, the hospital authority may charge the patient an amount not exceeding the amount that the patient could have been required to pay under subsection 87(2) of the Act if the patient had obtained a pharmaceutical benefit from an approved pharmacist.

Note: This is a single amount for supply of the dose, not a separate amount for supply of each chemotherapy pharmaceutical benefit used to make the dose.

(3) No amount may be charged under subsection (2) for a repeated supply. (3A) In addition, if the supply is made to an eligible patient who is a CTG registered patient by a CTG supplier, no amount may be charged under subsections 11(1) to (3) of the CTG Special Arrangement for a repeated supply.

Note: See section 40 of this instrument in relation to the application of the CTG Special Arrangement.

Special patient contribution for original or repeated supply (4) If a determination under subsection 85B(3) of the Act is in force in relation to a chemotherapy pharmaceutical benefit used to make the dose: (a) the hospital authority may charge a special patient contribution in accordance with the Act for supply of the benefit; and (b) subsection 85B(5) of the Act applies as if a reference to the Commonwealth price for a quantity or number of units of a listed brand of a pharmaceutical item were a reference to the dispensed price for a dose of a chemotherapy drug made using a quantity or number of units of a listed brand of a pharmaceutical item.